Clavister (CLAV) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Dec, 2025Executive summary
Net sales increased 23% year-over-year in Q4 2024 to SEK 59 million, with ARR up 14.4% to SEK 137.6 million and strong order intake of SEK 134 million across all business areas.
Order book at year-end reached SEK 300 million, mainly from defense and telecom sectors.
Significant defense order of SEK 53 million for CyberArmour to CV90 and SEK 8 million contract for marine applications.
Adjusted EBITDA margin improved to 17.3% in Q4 (from 14% last year); adjusted EBIT at -0.7 MSEK (from -6.8 MSEK).
No material events occurred after the reporting period.
Financial highlights
Q4 net sales: SEK 59.0 million (up 22.7% year-over-year); full year: SEK 191.7 million (up 19.4%).
Q4 adjusted EBITDA: SEK 10.6 million (up from SEK 6.8 million); full year: SEK 36.0 million (up from SEK 20.9 million).
Q4 adjusted EBIT: SEK -0.7 million (improved from SEK -6.8 million); full year: SEK -8.3 million (from -27.4 million).
Q4 net result after tax: SEK -17.4 million; full year: SEK -56.0 million.
Cash and cash equivalents at year-end: SEK 83.2 million.
Outlook and guidance
Targeting at least 20% CAGR in net sales for 2025–2027, with EBIT positive for full year 2025 and net profitability in 2026.
2025 ambition: EBITDA margin of at least 20%, positive EBIT, and positive operational cash flow despite increased sales and marketing investments.
Expecting continued ARR and net sales growth, with investments in sales and marketing to drive profitable growth.
Long-term goal to achieve industry-leading profitability and free cash flow.
Order intake momentum and recurring revenue model seen as sustainable for future quarters.
Latest events from Clavister
- Record order intake, strong defense wins, and improved financials drive future growth.CLAV
Q4 202512 Feb 2026 - Q2 net sales up 17% to 45M SEK, with strong order intake and positive cash flow.CLAV
Q2 202423 Jan 2026 - First positive EBIT, record margins, and strong order growth drive robust momentum.CLAV
Q3 202416 Jan 2026 - Double-digit growth, robust tech, and major defense contracts position for strong 2025 expansion.CLAV
ABGSC Investor Days12 Jan 2026 - Order intake up 52%, net sales up 22%, and gross margin at 81.1% with major defence wins.CLAV
Q2 202523 Nov 2025 - Order intake up 190% and net sales up 21%, led by major defense and hardware contracts.CLAV
Q1 202522 Nov 2025 - Record profitability and 15% sales growth, but supply delays impact near-term targets.CLAV
Q3 20256 Nov 2025